Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanjay Goel

Showing results (141-150 of 182) with videos related to

Pageof 19
Sort By:
Cancer Gene Therapy|August 22, 2024
Mesothelin expression correlates with elevated inhibitory immune activity in patients with colorectal cancerMidhun Malla, Sachin Kumar Deshmukh, Sharon Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
The effect of ketoconazole on the pharmacokinetics and pharmacodynamics of ixabepilone: a first in class epothilone B analogue in late-phase clinical developmentSanjay Goel, Marvin Cohen, S Nilgün Cömezoglu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2025
Distinct Molecular and Clinical Features of Specific Variants of KRAS Codon 12 in Pancreatic AdenocarcinomaBach Ardalan, Aaron Ciner, Yasmine Baca, et al.
Cancer Research|October 1, 2009
An A13 repeat within the 3'-untranslated region of epidermal growth factor receptor (EGFR) is frequently mutated in microsatellite instability colon cancers and is associated with increased EGFR expressionZiqiang Yuan, Joongho Shin, Andrew Wilson, et al.
Cancer Chemotherapy and Pharmacology|September 30, 2016
Randomized phase 1 crossover study assessing the bioequivalence of capsule and tablet formulations of dovitinib (TKI258) in patients with advanced solid tumorsJohn Sarantopoulos, Sanjay Goel, Vincent Chung, et al.
Cancer Medicine|July 6, 2024
Phase 1b study to assess the safety, tolerability, and clinical activity of pamiparib in combination with temozolomide in patients with locally advanced or metastatic solid tumorsAgostina Stradella, Melissa Johnson, Sanjay Goel, et al.
Cancers|April 27, 2024
The Genomic, Transcriptomic, and Immunologic Landscape of <i>HRAS</i> Mutations in Solid TumorsSamuel A Kareff, Asaad Trabolsi, Harris B Krause, et al.
JCO Precision Oncology|May 9, 2024
Genomic Profiling of Rare Undifferentiated Sarcomatoid Subtypes of Pancreatic Carcinomas: In Search of Therapeutic TargetsErik B Faber, Harris B Krause, Khalid Amin, et al.
Oncotarget|October 1, 2019
Excision repair cross-complementing group-1 (ERCC1) induction kinetics and polymorphism are markers of inferior outcome in patients with colorectal cancer treated with oxaliplatinDevika Rao, Atrayee Basu Mallick, Titto Augustine, et al.
FEBS Letters|October 22, 2002
Establishment of the enzymatic protein acetylation independent of acetyl CoA: recombinant glutathione S-transferase 3-3 is acetylated by a novel membrane-bound transacetylase using 7,8-diacetoxy-4-methyl coumarin as the acetyl donorEkta Kohli, Marco Gaspari, Hanumantharao G Raj, et al.
Pageof 19

Showing results (141-150 of 182) with videos related to

Sort By:
Pageof 19
Cancer Gene Therapy|August 22, 2024
Mesothelin expression correlates with elevated inhibitory immune activity in patients with colorectal cancerMidhun Malla, Sachin Kumar Deshmukh, Sharon Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
The effect of ketoconazole on the pharmacokinetics and pharmacodynamics of ixabepilone: a first in class epothilone B analogue in late-phase clinical developmentSanjay Goel, Marvin Cohen, S Nilgün Cömezoglu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2025
Distinct Molecular and Clinical Features of Specific Variants of KRAS Codon 12 in Pancreatic AdenocarcinomaBach Ardalan, Aaron Ciner, Yasmine Baca, et al.
Cancer Research|October 1, 2009
An A13 repeat within the 3'-untranslated region of epidermal growth factor receptor (EGFR) is frequently mutated in microsatellite instability colon cancers and is associated with increased EGFR expressionZiqiang Yuan, Joongho Shin, Andrew Wilson, et al.
Cancer Chemotherapy and Pharmacology|September 30, 2016
Randomized phase 1 crossover study assessing the bioequivalence of capsule and tablet formulations of dovitinib (TKI258) in patients with advanced solid tumorsJohn Sarantopoulos, Sanjay Goel, Vincent Chung, et al.
Cancer Medicine|July 6, 2024
Phase 1b study to assess the safety, tolerability, and clinical activity of pamiparib in combination with temozolomide in patients with locally advanced or metastatic solid tumorsAgostina Stradella, Melissa Johnson, Sanjay Goel, et al.
Cancers|April 27, 2024
The Genomic, Transcriptomic, and Immunologic Landscape of <i>HRAS</i> Mutations in Solid TumorsSamuel A Kareff, Asaad Trabolsi, Harris B Krause, et al.
JCO Precision Oncology|May 9, 2024
Genomic Profiling of Rare Undifferentiated Sarcomatoid Subtypes of Pancreatic Carcinomas: In Search of Therapeutic TargetsErik B Faber, Harris B Krause, Khalid Amin, et al.
Oncotarget|October 1, 2019
Excision repair cross-complementing group-1 (ERCC1) induction kinetics and polymorphism are markers of inferior outcome in patients with colorectal cancer treated with oxaliplatinDevika Rao, Atrayee Basu Mallick, Titto Augustine, et al.
FEBS Letters|October 22, 2002
Establishment of the enzymatic protein acetylation independent of acetyl CoA: recombinant glutathione S-transferase 3-3 is acetylated by a novel membrane-bound transacetylase using 7,8-diacetoxy-4-methyl coumarin as the acetyl donorEkta Kohli, Marco Gaspari, Hanumantharao G Raj, et al.
Pageof 19